[1]
M. Sato, “Prescribing of GLP-1 and GIP/GLP-1 Receptor Agonists and Other Glucose-Lowering Drugs Requiring Special Caution in Elderly Japanese People With Type 2 Diabetes: A Preliminary Report”, J Clin Med Res, vol. 18, no. 5, pp. 292–300, Jan. 2026, doi: 10.14740/jocmr6532.